Symbol="ADMP"
AssetType="Common Stock"
Name="Adamis Pharma"
Description="Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California."
CIK="887247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="7601500"
EBITDA="-17794120"
PERatio="None"
PEGRatio="0"
BookValue="-4.238"
DividendPerShare="0"
DividendYield="0"
EPS="-9.94"
RevenuePerShareTTM="2.222"
ProfitMargin="0"
OperatingMarginTTM="-3.736"
ReturnOnAssetsTTM="-1.045"
ReturnOnEquityTTM="-7.85"
RevenueTTM="5021700"
GrossProfitTTM="-1431408"
DilutedEPSTTM="-9.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.826"
AnalystTargetPrice="0.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="8.62"
EVToRevenue="15.59"
EVToEBITDA="-0.784"
Beta="1.208"
num_52WeekHigh="26.18"
num_52WeekLow="0.77"
num_50DayMovingAverage="1.669"
num_200DayMovingAverage="7.92"
SharesOutstanding="9359100"
DividendDate="None"
ExDividendDate="None"
symbol="ADMP"
open="0.86"
high="0.86"
low="0.79"
price="0.81"
volume="234334.00"
latest_trading_day="2023-08-30"
previous_close="0.85"
change="-0.04"
change_percent="-4.5257%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="1"
Volume_recent_avg="1913621"
Change_recent_avg="0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-2.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
